Union Bankshares Corporation (UBSH) has risen 21.53% since January 11, 2017 and is uptrending.
Willingdon Wealth Management increased Abbvie Inc (ABBV) stake by 118.55% reported in 2017Q3 SEC filing. Capital Research Global Investors now owns 178,274,835 shares of the company's stock valued at $12,926,708,000 after buying an additional 2,130,919 shares during the period. The institutional investor held 23,313 shares of the telecommunications equipment company at the end of 2017Q3, valued at $913,000, up from 1,000 at the end of the previous reported quarter. The overall volume in the last trading session was 4.61 million shares. About 3.21M shares traded.
Ingalls & Snyder LLC grew its holdings in shares of AbbVie Inc (NYSE:ABBV) by 58.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. It has underperformed by 4.16% the S&P500. About 3.09M shares traded. On average, equities research analysts predict that AbbVie will post $5.49 earnings per share for the current year. A 9 analysts rate it as either a buy or a strong buy, while3 believe that investors should either steer clear of BWA or, if they already own its stock, sell it. Therefore 85% are positive. Credit Suisse Group lowered shares of AbbVie from an outperform rating to a neutral rating and lowered their price objective for the company from $70.00 to $60.00 in a research report on Monday, October 31st. AbbVie Inc has a one year low of $59.27 and a one year high of $101.28. The rating was upgraded by Stifel Nicolaus to "Buy" on Thursday, August 27. The stock has "Buy" rating by UBS on Friday, October 16. Finally, Evercore ISI reiterated an "outperform" rating and set a $100.00 target price (up previously from $95.00) on shares of AbbVie in a research report on Saturday, September 30th. The company was maintained on Thursday, November 16 by BMO Capital Markets. Morgan Stanley downgraded AbbVie Inc. The firm has "Overweight" rating by Mitsubishi UFJ given on Wednesday, March 1. The 1 year EPS growth rate is 15.60%. The rating was maintained by Cowen & Co on Tuesday, September 5 with "Hold". (NYSE:ABBV). Salem Counselors Incorporated holds 1.02% or 97,970 shares in its portfolio. Rockland Trust Co sold 11,103 shares as the company's stock declined 11.45% while stock markets rallied. AbbVie makes up about 1.9% of Harvey Investment Co. Its up 0.18, from 0.67 in 2017Q2. Hollencrest Ltd Liability Com has invested 0.09% in AbbVie Inc. Tortoise Cap Advsr Ltd Liability Corp holds 5.22% or 22.79 million shares. American Natl Ins Company Tx reported 0.75% of its portfolio in AbbVie Inc. (NYSE:ABBV) rating on Monday, July 17. Vaughan Nelson Investment Management L.P. owns 2.20 million shares or 0.92% of their USA portfolio. Federated Investors Pa reported 10.64 million shares. Covington Advisors stated it has 30,836 shares. The Germany-based Deutsche National Bank & Trust Ag has invested 0.05% in National Oilwell Varco, Inc. After $1.41 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42 % EPS growth. Shares of BWA have uptrended 7.19% in the past three months, while the S&P 500 has moved -1.47% in that time. Associated Banc has invested 0.31% in AbbVie Inc. (NYSE:C) for 266 shares. A 11 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NYSE:ABBV) or, if they already own its stock, sell it. Its down 0.15, from 1 in 2017Q2. Of those transactions, there were 484,937 shares of ABBV bought and 1.57 million shares sold.
Several hedge funds have recently added to or reduced their stakes in ABBV. It also upped Blue Chip stake by 33,442 shares and now owns 312,171 shares. Blue Granite Capital LLC's holdings in AbbVie were worth $1,822,000 at the end of the most recent reporting period.
Shares of AbbVie Inc (ABBV) opened at $99.69 on Thursday. Counselors Of Maryland Ltd Liability Company reported 0.05% stake. 49,016 were accumulated by Wellington Shields Capital Ltd. 814,452 were reported by Blair William & Il. Bahl And Gaynor invested in 2.12M shares or 2.06% of the stock. 42,475 were reported by Wharton Business Grp Ltd Liability. Adirondack Tru holds 0% or 160 shares in its portfolio. 34,238 are owned by Greatmark Partners. (NYSE:ABBV). Armstrong Henry H Associate holds 0.4% or 24,841 shares.
Since July 31, 2017, it had 0 insider buys, and 8 insider sales for $45.57 million activity. The insider RICHMOND TIMOTHY J. sold 87,040 shares worth $8.57 million. Also, EVP Michael Severino sold 25,633 shares of AbbVie stock in a transaction that occurred on Friday, November 10th. (NYSE:ABBV) as Buy, 0 analysts given Outperform signal, 3 reported Hold, and 0 analysts rated the stock as Sell. Schumacher Laura J sold 145,510 shares worth $14.07M.
AMETEK, Inc. (NYSE:AME) presented as an active mover, it has floated short ration of 1.08%, hold to candle to sentiment indicator of Short Ratio, which was 1.97. Therefore 52% are positive. Adecoagro S.A. had 4 analyst reports since September 28, 2015 according to SRatingsIntel. The stock of AbbVie Inc. Barclays reissued a "hold" rating and set a $68.00 price objective on shares of AbbVie in a report on Thursday, September 28th. As per Tuesday, July 18, the company rating was maintained by Cowen & Co. Societe Generale initiated the shares of ABBV in report on Wednesday, April 6 with "Sell" rating. The company was maintained on Wednesday, December 20 by Jefferies. The firm has "Buy" rating by BMO Capital Markets given on Monday, April 24. The rating was initiated by Leerink Swann with "Mkt Perform" on Tuesday, October 18. The firm has "Buy" rating given on Tuesday, February 23 by Citigroup.
Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
Credit Suisse Group Initiates Coverage on Plains GP (PAGP)
Its up 0.17, from 1.06 in 2017Q2. 40 funds opened positions while 72 raised stakes. (NYSE:D) to report earnings on February, 7. The pipeline company reported $0.03 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.23 by ($0.20).